A Cautionary Tale of Combination Ceftriaxone and Lansoprazole: Should Pediatric Clinicians Heed the Warning?
作者信息
Israel Emily N, Nichols Kristen R, Knoderer Chad A
机构信息
College of Pharmacy (ENI), Purdue University, West Lafayette, IN.
College of Pharmacy and Health Sciences (CAK), Butler University, Indianapolis, IN.
出版信息
J Pediatr Pharmacol Ther. 2025 Jun;30(3):407-409. doi: 10.5863/JPPT-25-01206. Epub 2025 Jun 9.
Abstract
摘要
相似文献
1
A Cautionary Tale of Combination Ceftriaxone and Lansoprazole: Should Pediatric Clinicians Heed the Warning?头孢曲松与兰索拉唑联用的警示故事：儿科临床医生应留意此警示吗？
J Pediatr Pharmacol Ther. 2025 Jun;30(3):407-409. doi: 10.5863/JPPT-25-01206. Epub 2025 Jun 9.
2
Concomitant use of lansoprazole and ceftriaxone is associated with an increased risk of ventricular arrhythmias and cardiac arrest in a large Japanese hospital database.在一个大型日本医院数据库中，兰索拉唑和头孢曲松的联合使用与室性心律失常和心脏骤停风险增加相关。
J Infect. 2024 Aug;89(2):106202. doi: 10.1016/j.jinf.2024.106202. Epub 2024 Jun 17.
3
Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole.头孢曲松与接受兰索拉唑治疗的患者发生室性心律失常、心脏骤停和死亡的风险。
JAMA Netw Open. 2023 Oct 2;6(10):e2339893. doi: 10.1001/jamanetworkopen.2023.39893.
4
Ceftriaxone induced pancreatitis: A case report with review of literature.头孢曲松诱发的胰腺炎：一例病例报告并文献复习
IDCases. 2025 May 28;40:e02273. doi: 10.1016/j.idcr.2025.e02273. eCollection 2025.
5
The mysterious case of missing lymphocytes: a cautionary tale of interinstitutional variability in outcomes of lung dissociation protocols.淋巴细胞缺失的神秘案例：肺解离方案结果机构间差异的警示故事
Am J Physiol Lung Cell Mol Physiol. 2025 Feb 1;328(2):L260-L266. doi: 10.1152/ajplung.00323.2024. Epub 2025 Jan 9.
6
Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation.结合数据挖掘与实验室实验以发现导致QT间期延长的药物相互作用
J Am Coll Cardiol. 2016 Oct 18;68(16):1756-1764. doi: 10.1016/j.jacc.2016.07.761.
7
Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit Hearts.质子泵抑制剂与头孢菌素类药物同时使用不会增强兔离体心脏的 QT 相关致心律失常作用。
Cardiovasc Toxicol. 2020 Dec;20(6):531-538. doi: 10.1007/s12012-020-09577-3.
8
Complicated Meckel's diverticulum concealed by massive mucinous ovarian carcinoma - A case report of the cautionary tale of surgical tunnel vision.巨大黏液性卵巢癌掩盖下的复杂梅克尔憩室——一则关于手术视野局限警示故事的病例报告
Int J Surg Case Rep. 2025 Jul;132:111467. doi: 10.1016/j.ijscr.2025.111467. Epub 2025 May 26.
9
The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69).妊娠恶心呕吐和妊娠剧吐的管理（绿皮指南第 69 号）。
BJOG. 2024 Jun;131(7):e1-e30. doi: 10.1111/1471-0528.17739. Epub 2024 Feb 4.
10
Probiotics for treatment of chronic constipation in children.益生菌治疗儿童慢性便秘。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD014257. doi: 10.1002/14651858.CD014257.pub2.
本文引用的文献
1
Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole.头孢曲松与接受兰索拉唑治疗的患者发生室性心律失常、心脏骤停和死亡的风险。
JAMA Netw Open. 2023 Oct 2;6(10):e2339893. doi: 10.1001/jamanetworkopen.2023.39893.
2
The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients.危重症患者中质子泵抑制剂与QT间期延长的关联
Cardiovasc Drugs Ther. 2024 Jun;38(3):517-525. doi: 10.1007/s10557-023-07425-4. Epub 2023 Jan 10.
3
Clinical Use of Gastric Antisecretory Drugs in Hospitalized Pediatric Patients.住院儿科患者胃抗分泌药物的临床应用
J Clin Med. 2023 Jan 3;12(1):368. doi: 10.3390/jcm12010368.
4
Proton pump inhibitors are still overprescribed for hospitalized children.质子泵抑制剂仍被过度开具给住院儿童。
Arch Pediatr. 2022 May;29(4):258-262. doi: 10.1016/j.arcped.2022.02.004. Epub 2022 Mar 16.
5
Torsade de pointe due to QT prolongation following erythromycin administration in a preterm infant.早产儿因红霉素治疗致尖端扭转型室速。
Acta Cardiol. 2022 Sep;77(7):597-601. doi: 10.1080/00015385.2021.1968153. Epub 2021 Aug 23.
6
Proton Pump Inhibitors Directly Block hERG-Potassium Channel and Independently Increase the Risk of QTc Prolongation in a Large Cohort of US Veterans.质子泵抑制剂直接阻断人醚-去极化激活的钾离子通道（hERG），并独立增加一大群美国退伍军人QTc间期延长的风险。
Circ Arrhythm Electrophysiol. 2021 Jul;14(7):e010042. doi: 10.1161/CIRCEP.121.010042. Epub 2021 Jun 18.
7
Pharmacotherapy Management for COVID-19 and Cardiac Safety: A Data Mining Approach for Pharmacovigilance Evidence from the FDA Adverse Event Reporting System (FAERS).新型冠状病毒肺炎的药物治疗管理与心脏安全性：一种基于美国食品药品监督管理局不良事件报告系统（FAERS）进行药物警戒证据挖掘的数据方法。
Drugs Real World Outcomes. 2021 Jun;8(2):131-140. doi: 10.1007/s40801-021-00229-8. Epub 2021 Feb 10.
8
Variability in Ceftriaxone Dosing Across 32 US Acute Care Children's Hospitals.32 家美国急性护理儿童医院头孢曲松剂量的变异性。
J Pediatric Infect Dis Soc. 2021 May 28;10(5):677-681. doi: 10.1093/jpids/piab004.
9
Parenteral Antibiotic Use Among Ambulatory Children in United States Children's Hospital Emergency Departments.美国儿童医院急诊科门诊患儿的肠外抗生素使用情况
Open Forum Infect Dis. 2020 Oct 22;7(10):ofaa357. doi: 10.1093/ofid/ofaa357. eCollection 2020 Oct.
10
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association.药物性心律失常：美国心脏协会的科学声明。
Circulation. 2020 Oct 13;142(15):e214-e233. doi: 10.1161/CIR.0000000000000905. Epub 2020 Sep 15.
Zotero 插件